Login to Your Account



Fluvirin Production Beginning Again As MHRA Clears Chiron

By Aaron Lorenzo


Thursday, March 3, 2005
Chiron Corp. received clearance to begin producing its flu vaccine again. The Emeryville, Calif.-based company, which last year lost its license to manufacture Fluvirin, received word that the UK's Medicines and Healthcare products Regulatory Agency (MHRA) lifted its suspension of a manufacturing facility in Liverpool, where the vaccine is produced. The news boosted Chiron's stock (NASDAQ:CHIR) by 6.4 percent Wednesday, as the shares gained $2.27 to close at $37.69. (BioWorld Today)

To continue reading subscribe now to BioWorld Today

Learn More about BioWorld Today

Already a subscriber? Sign In or Buy now to activate your subscription